Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8221209
[patent_doc_number] => 20120135402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'GENE SEQUENCE VARIANCES IN GENES RELATED TO FOLATE METABOLISM HAVING UTILITY IN DETERMINING THE TREATMENT OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/112371
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 64762
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112371
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112371 | GENE SEQUENCE VARIANCES IN GENES RELATED TO FOLATE METABOLISM HAVING UTILITY IN DETERMINING THE TREATMENT OF DISEASE | May 19, 2011 | Abandoned |
Array
(
[id] => 8884689
[patent_doc_number] => 20130157873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS'
[patent_app_type] => utility
[patent_app_number] => 13/698907
[patent_app_country] => US
[patent_app_date] => 2011-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8821
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/698907 | METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS | May 18, 2011 | Abandoned |
Array
(
[id] => 8684360
[patent_doc_number] => 20130052644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)'
[patent_app_type] => utility
[patent_app_number] => 13/695214
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18637
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695214
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/695214 | Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS) | Apr 27, 2011 | Abandoned |
Array
(
[id] => 9823327
[patent_doc_number] => 08932810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Identification of mutation and method for detecting lavender foal syndrome in the horse'
[patent_app_type] => utility
[patent_app_number] => 13/093173
[patent_app_country] => US
[patent_app_date] => 2011-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8254
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13093173
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/093173 | Identification of mutation and method for detecting lavender foal syndrome in the horse | Apr 24, 2011 | Issued |
Array
(
[id] => 8140605
[patent_doc_number] => 20120094854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENE SIGNATURE'
[patent_app_type] => utility
[patent_app_number] => 13/093543
[patent_app_country] => US
[patent_app_date] => 2011-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24407
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094854.pdf
[firstpage_image] =>[orig_patent_app_number] => 13093543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/093543 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENE SIGNATURE | Apr 24, 2011 | Abandoned |
Array
(
[id] => 8815099
[patent_doc_number] => 20130116144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'METHYLATION MARKER FOR DIAGNOSIS OF CERVICAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/642407
[patent_app_country] => US
[patent_app_date] => 2011-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11681
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642407
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/642407 | METHYLATION MARKER FOR DIAGNOSIS OF CERVICAL CANCER | Apr 21, 2011 | Abandoned |
Array
(
[id] => 6046657
[patent_doc_number] => 20110206667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/090116
[patent_app_country] => US
[patent_app_date] => 2011-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17202
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20110206667.pdf
[firstpage_image] =>[orig_patent_app_number] => 13090116
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/090116 | POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT | Apr 18, 2011 | Abandoned |
Array
(
[id] => 10122771
[patent_doc_number] => 09157123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Genetic amplification of IQGAP1 in cancer'
[patent_app_type] => utility
[patent_app_number] => 13/641994
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7942
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641994
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641994 | Genetic amplification of IQGAP1 in cancer | Apr 14, 2011 | Issued |
Array
(
[id] => 7574079
[patent_doc_number] => 20110269735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/085955
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61758
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269735.pdf
[firstpage_image] =>[orig_patent_app_number] => 13085955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/085955 | GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF | Apr 12, 2011 | Abandoned |
Array
(
[id] => 8139681
[patent_doc_number] => 20120094389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes'
[patent_app_type] => utility
[patent_app_number] => 13/084187
[patent_app_country] => US
[patent_app_date] => 2011-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9183
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094389.pdf
[firstpage_image] =>[orig_patent_app_number] => 13084187
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/084187 | Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes | Apr 10, 2011 | Abandoned |
Array
(
[id] => 7487916
[patent_doc_number] => 20110251252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'BIOMARKERS FOR MDM2 INHIBITORS FOR USE IN TREATING DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/082163
[patent_app_country] => US
[patent_app_date] => 2011-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21699
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251252.pdf
[firstpage_image] =>[orig_patent_app_number] => 13082163
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/082163 | BIOMARKERS FOR MDM2 INHIBITORS FOR USE IN TREATING DISEASE | Apr 6, 2011 | Abandoned |
Array
(
[id] => 5958948
[patent_doc_number] => 20110183335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR PERIOPERATIVE GENOMIC PROFILING'
[patent_app_type] => utility
[patent_app_number] => 13/078587
[patent_app_country] => US
[patent_app_date] => 2011-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19991
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183335.pdf
[firstpage_image] =>[orig_patent_app_number] => 13078587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/078587 | METHODS AND COMPOSITIONS FOR PERIOPERATIVE GENOMIC PROFILING | Mar 31, 2011 | Abandoned |
Array
(
[id] => 7696711
[patent_doc_number] => 20110229879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR NUCLEAR STAINING'
[patent_app_type] => utility
[patent_app_number] => 13/052791
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3937
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229879.pdf
[firstpage_image] =>[orig_patent_app_number] => 13052791
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052791 | METHODS AND COMPOSITIONS FOR NUCLEAR STAINING | Mar 20, 2011 | Abandoned |
Array
(
[id] => 7500366
[patent_doc_number] => 20110262915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'METHOD FOR PREDICTING THE ATHLETIC PERFORMANCE POTENTIAL OF A SUBJECT'
[patent_app_type] => utility
[patent_app_number] => 13/046432
[patent_app_country] => US
[patent_app_date] => 2011-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16523
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262915.pdf
[firstpage_image] =>[orig_patent_app_number] => 13046432
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/046432 | METHOD FOR PREDICTING THE ATHLETIC PERFORMANCE POTENTIAL OF A SUBJECT | Mar 10, 2011 | Abandoned |
Array
(
[id] => 6014890
[patent_doc_number] => 20110223180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'METHODS AND COMPOSITIONS RELATED TO A MULTI-METHYLATION ASSAY TO PREDICT PATIENT OUTCOME'
[patent_app_type] => utility
[patent_app_number] => 13/044934
[patent_app_country] => US
[patent_app_date] => 2011-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13906
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223180.pdf
[firstpage_image] =>[orig_patent_app_number] => 13044934
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/044934 | METHODS AND COMPOSITIONS RELATED TO A MULTI-METHYLATION ASSAY TO PREDICT PATIENT OUTCOME | Mar 9, 2011 | Abandoned |
Array
(
[id] => 6161213
[patent_doc_number] => 20110159494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'Analyzing the FMR1 Gene'
[patent_app_type] => utility
[patent_app_number] => 13/043199
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 34939
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159494.pdf
[firstpage_image] =>[orig_patent_app_number] => 13043199
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/043199 | Analyzing the FMR1 Gene | Mar 7, 2011 | Abandoned |
Array
(
[id] => 7663265
[patent_doc_number] => 20110312534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'METHOD FOR PREDICTION OF HUMAN IRIS COLOR'
[patent_app_type] => utility
[patent_app_number] => 13/041109
[patent_app_country] => US
[patent_app_date] => 2011-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27647
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312534.pdf
[firstpage_image] =>[orig_patent_app_number] => 13041109
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/041109 | METHOD FOR PREDICTION OF HUMAN IRIS COLOR | Mar 3, 2011 | Abandoned |
Array
(
[id] => 7567367
[patent_doc_number] => 20110287430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'NON-THIOPURINE METHYLTRANSFERASE RELATED EFFECTS IN 6-MERCAPTOPURINE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/039505
[patent_app_country] => US
[patent_app_date] => 2011-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8675
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287430.pdf
[firstpage_image] =>[orig_patent_app_number] => 13039505
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/039505 | Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy | Mar 2, 2011 | Issued |
Array
(
[id] => 9112815
[patent_doc_number] => 08568984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation'
[patent_app_type] => utility
[patent_app_number] => 13/030888
[patent_app_country] => US
[patent_app_date] => 2011-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 15135
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13030888
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/030888 | Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation | Feb 17, 2011 | Issued |
Array
(
[id] => 8617662
[patent_doc_number] => 20130022975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'METHOD FOR DETECTING ARTERIOSCLEROTIC DISEASES ON THE BASIS OF SINGLE NUCLEOTIDE POLYMORPHISM AT HUMAN CHROMOSOME 5P15.3'
[patent_app_type] => utility
[patent_app_number] => 13/579463
[patent_app_country] => US
[patent_app_date] => 2011-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5231
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/579463 | METHOD FOR DETECTING ARTERIOSCLEROTIC DISEASES ON THE BASIS OF SINGLE NUCLEOTIDE POLYMORPHISM AT HUMAN CHROMOSOME 5P15.3 | Feb 17, 2011 | Abandoned |